Healthcare

A medical assessment served under the Wrongs Act by a patient of Dr Daniel Lanzer needed to come to the attention of the surgeon himself, not just his solicitors, despite the lawyers being authorised to receive other documents in the case, an appeals court has found. 

A class action against Bupa alleging the aged care provider failed to provide promised levels of care to residents can proceed, with a judge finding the case is not "fatally flawed".

Mayne Pharma says it, and not US drug maker Cosette, has terminated their $672 merger agreement and that it is therefore not on the hook for a break fee.

A court has slapped private health insurer Bupa with a $35 million penalty after it admitted to misleading thousands of customers about their benefits for over five years.

Setting up another potential legal fight, Mayne Pharma has said US drug maker Cosette did not validly terminate their $672 million merger agreement, which failed to receive FIRB approval.

Johnson & Johnson-owned Janssen has secured an injunction against drug maker Juno Pharmaceuticals, halting the release of Juno's generic version of schizophrenia drug Invega Sustenna.

Ramsay Health Care has lost its challenge to development approval for a community health care services centre near its Greenslopes Hospital in Brisbane, with a court finding the centre would not interfere with the hospital’s operations. 

The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.

Nine wants indemnity costs against celebrity surgeon Munjed Al Muderis, claiming his defamation case over reports critical of his promotion of an experimental procedure, which the court found were substantially true, was an abuse of process.

Kennedys has lured a lawyer away from Wotton Kearney to join the healthcare practice in its Brisbane office.